Danielle Ford, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26622 Cook Field Rd Ste 200, Katy, TX 77494 Phone: 281-766-3831 |
Marla Collison-brown, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6301 S Stadium Ln, Katy, TX 77494 Phone: 281-396-6000 |
Communicare Associates Inc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22503 Katy Fwy Ste 3, Katy, TX 77450 Phone: 281-392-8173 Fax: 281-392-8239 |
Alexis Innes Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 26100 Cinco Ranch Blvd, Katy, TX 77494 Phone: 281-237-7600 |
April Linton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6301 S Stadium Ln, Katy, TX 77494 Phone: 361-774-5200 |
Melissa Hubbard Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8906 Bluehaw Mdw Ln, Katy, TX 77494 Phone: 832-452-6989 |
Diana Vaccaro, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20615 Fawnbrook Ct, Katy, TX 77450 Phone: 646-645-2001 Fax: 281-829-7897 |
Ruth Maddock Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3715 Rocky Ledge Ln, Katy, TX 77494 Phone: 713-501-2968 |
Maria Del Pilar Londono, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1260 Pin Oak Rd, Suite 108, Katy, TX 77494 Phone: 281-395-5599 Fax: 281-395-5615 |
Mrs. Betty Cecilia Contreras, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3318 Fairmont Hills Ln, Katy, TX 77494 Phone: 631-855-2491 |
Ileana Gonzalez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6622 Ryan Hills Ct, Katy, TX 77449 Phone: 713-732-8530 |
Sarah Chavez Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6906 Durango Creek Ln, Katy, TX 77449 Phone: 832-341-5771 |
I Kan Be Bilingual Slp Therapy Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1846 Snake River Rd Ste B, Katy, TX 77449 Phone: 281-741-5576 |
Lindsay Chargois Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20400 W Little York Rd, Katy, TX 77449 Phone: 281-856-9870 |
Erika Joy Pringle, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2002 S Mason Rd Apt 927, Katy, TX 77450 Phone: 832-815-2028 |
Ashley Powers Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6301 S Stadium Ln, Katy, TX 77494 Phone: 281-396-2562 |
Ahlam Musa Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6301 S Stadium Ln, Katy, TX 77494 Phone: 281-237-5959 |
Yasiela Castro Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1260 Pin Oak Rd Ste 108, Katy, TX 77494 Phone: 346-631-6599 |
Prachi Tare, MSCCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1260 Pin Oak Rd, Suite 108, Katy, TX 77494 Phone: 408-429-3099 |
Cynthia Sipperly Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1736 Katyland Drive, Katy, TX 77493 Phone: 281-237-2753 |
News Archive
Precision medicine requires big data. In order to improve the treatment of individuals with cancer, or to understand rare diseases, scientists and clinicians, as well as AI technologies require access to larger sets of health research data that covers diverse populations and wide ranges of conditions.
A University of Pennsylvania researcher has discovered that the common selective serotonin reuptake inhibitor (SSRI) citalopram arrested the growth of amyloid beta, a peptide in the brain that clusters in plaques that are thought to trigger the development of Alzheimer's disease (AD).
Omeros Corporation today announced that it has filed an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) to initiate clinical trials evaluating OMS824, the Company's lead compound from its phosphodiesterase 10 (PDE10) program for schizophrenia and other cognitive disorders.
A device proposed by researchers at Sweden's KTH Royal Institute of Technology could offer a more reliable alternative for detecting biomarkers in patients facing such illnesses as cancer or malaria.
› Verified 7 days ago